MXPA06006187A - Imitadores de super oxido dismutasa para el tratamiento de dano retinal y de nervio optico. - Google Patents

Imitadores de super oxido dismutasa para el tratamiento de dano retinal y de nervio optico.

Info

Publication number
MXPA06006187A
MXPA06006187A MXPA06006187A MXPA06006187A MXPA06006187A MX PA06006187 A MXPA06006187 A MX PA06006187A MX PA06006187 A MXPA06006187 A MX PA06006187A MX PA06006187 A MXPA06006187 A MX PA06006187A MX PA06006187 A MXPA06006187 A MX PA06006187A
Authority
MX
Mexico
Prior art keywords
alkyl
heteroaryl
group
cycloalkenyl
cycloalkyl
Prior art date
Application number
MXPA06006187A
Other languages
English (en)
Spanish (es)
Inventor
Peter G Klimko
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MXPA06006187A publication Critical patent/MXPA06006187A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
MXPA06006187A 2003-12-11 2004-11-30 Imitadores de super oxido dismutasa para el tratamiento de dano retinal y de nervio optico. MXPA06006187A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52883003P 2003-12-11 2003-12-11
PCT/US2004/039830 WO2005060974A1 (en) 2003-12-11 2004-11-30 Superoxide dismutase mimics for the treatment of optic nerve and retinal damage

Publications (1)

Publication Number Publication Date
MXPA06006187A true MXPA06006187A (es) 2006-08-25

Family

ID=34710102

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06006187A MXPA06006187A (es) 2003-12-11 2004-11-30 Imitadores de super oxido dismutasa para el tratamiento de dano retinal y de nervio optico.

Country Status (12)

Country Link
US (3) US20070060557A1 (cg-RX-API-DMAC7.html)
EP (1) EP1691815A4 (cg-RX-API-DMAC7.html)
JP (1) JP2007513948A (cg-RX-API-DMAC7.html)
KR (1) KR20060101501A (cg-RX-API-DMAC7.html)
CN (1) CN1889961A (cg-RX-API-DMAC7.html)
AU (1) AU2004305531B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0417549A (cg-RX-API-DMAC7.html)
CA (1) CA2545762A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06006187A (cg-RX-API-DMAC7.html)
RU (1) RU2006124746A (cg-RX-API-DMAC7.html)
WO (1) WO2005060974A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200603347B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1889961A (zh) * 2003-12-11 2007-01-03 爱尔康公司 用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物
KR100724586B1 (ko) 2005-12-09 2007-06-04 세종대학교산학협력단 수퍼옥사이드 디스뮤타아제 활성을 갖는 고리화합물
US8598150B1 (en) 2008-04-02 2013-12-03 Jonathan R. Brestoff Composition and method for affecting obesity and related conditions
US8987245B2 (en) 2008-04-02 2015-03-24 Jonathan R. Brestoff Parker Composition and method for affecting obesity and related conditions
US20190388548A1 (en) * 2018-06-26 2019-12-26 Tzu Chi University Method for providing ocular neuroprotection or for preventing, treating or alleviating the effects of, an ocular disease associated with retinal ganglion cell death

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550022A (en) * 1981-10-05 1985-10-29 Alcon Laboratories, Inc. Tissue irrigating solution
DE3773926D1 (de) * 1987-07-22 1991-11-21 Farvalsa Ag Feuchtigkeitsstabile feste valproinsaeure-zubereitung und verfahren zu ihrer herstellung.
US6127356A (en) * 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5994339A (en) * 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
SE9402816D0 (sv) * 1994-08-24 1994-08-24 Pharmacia Ab Method and meams for drug administration
US6180620B1 (en) * 1997-06-20 2001-01-30 G.D. Searle & Co. Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
US6214817B1 (en) * 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
AU5251999A (en) 1998-08-04 2000-02-28 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
GB9817845D0 (en) * 1998-08-17 1998-10-14 Glaxo Group Ltd Chemical compounds
WO2000023568A2 (en) 1998-10-06 2000-04-27 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells
ES2240101T3 (es) 1999-05-27 2005-10-16 Monsanto Company Biomateriales modificados con mimeticos de superoxido dismutasa.
DE60231246D1 (de) * 2001-12-14 2009-04-02 Alcon Inc Superoxiddismutas-mimetika zur behandlung von augenerkrankungen
CN1889961A (zh) * 2003-12-11 2007-01-03 爱尔康公司 用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物

Also Published As

Publication number Publication date
AU2004305531A1 (en) 2005-07-07
WO2005060974A1 (en) 2005-07-07
AU2004305531B2 (en) 2009-11-26
EP1691815A4 (en) 2010-03-31
US20070060557A1 (en) 2007-03-15
US20110105453A1 (en) 2011-05-05
US20050130951A1 (en) 2005-06-16
CN1889961A (zh) 2007-01-03
ZA200603347B (en) 2009-02-25
CA2545762A1 (en) 2005-07-07
EP1691815A1 (en) 2006-08-23
KR20060101501A (ko) 2006-09-25
RU2006124746A (ru) 2008-01-20
JP2007513948A (ja) 2007-05-31
BRPI0417549A (pt) 2007-03-27

Similar Documents

Publication Publication Date Title
US8003635B2 (en) Superoxide dismutase mimics for the treatment of ocular disorders and diseases
AU2003298917A1 (en) Superoxide dismutase mimics for the treatment of ocular disorders and diseases
US8067405B2 (en) Superoxide dismutase mimics for the treatment of ocular disorders and diseases
US20110105453A1 (en) Superoxide Dismutase Mimics For The Treatment Of Optic Nerve And Retinal Damage
AU2002351267B8 (en) Superoxide dismutase mimics for the treatment of ocular disorders and diseases
HK1069785B (en) Superoxide dismutase mimics for the treatment of ocular disorders and diseases